Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single fiber electromyography: what type of needle should I use?
Papathanasiou ES, Zamba-Papanicolaou E. Papathanasiou ES, et al. Clin Neurophysiol. 2013 Nov;124(11):2077-8. doi: 10.1016/j.clinph.2013.05.018. Epub 2013 Jun 17. Clin Neurophysiol. 2013. PMID: 23786795 No abstract available.
Neurogenic vestibular evoked potentials using a tone pip auditory stimulus.
Papathanasiou ES, Zamba-Papanicolaou E, Pantziaris M, Kleopas K, Kyriakides T, Papacostas S, Pattichis C, Iliopoulos I, Piperidou C. Papathanasiou ES, et al. Electromyogr Clin Neurophysiol. 2004 Apr-May;44(3):167-73. Electromyogr Clin Neurophysiol. 2004. PMID: 15125057
The exhaustibility of Lambert-Eaton myasthenic syndrome.
Papathanasiou ES, Zamba-Papanicolaou E. Papathanasiou ES, et al. Clin Neurophysiol. 2014 Feb;125(2):220. doi: 10.1016/j.clinph.2013.09.022. Epub 2013 Oct 11. Clin Neurophysiol. 2014. PMID: 24125855 No abstract available.
A novel case of inclusion body myositis and myasthenia gravis.
Lambrianides S, Kinnis E, Cleanthous M, Papacharalambous R, Panayiotou E, Zamba-Papanicolaou E, Kyriakides T. Lambrianides S, et al. Neuromuscul Disord. 2019 Oct;29(10):771-775. doi: 10.1016/j.nmd.2019.09.004. Epub 2019 Sep 6. Neuromuscul Disord. 2019. PMID: 31604651
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ. Zisimopoulou P, et al. J Autoimmun. 2014 Aug;52:139-45. doi: 10.1016/j.jaut.2013.12.004. Epub 2013 Dec 24. J Autoimmun. 2014. PMID: 24373505
60 results